Similar articles for PMID: 31141607

Year	Number of Results
1997	2
2003	1
2006	1
2007	2
2008	3
2009	1
2010	3
2011	7
2012	4
2013	13
2014	9
2015	12
2016	20
2017	9
2018	10
2019	19
2020	21
2021	20
2022	19
2023	9
2024	0

1

Anti-TNF Therapy in Pregnant Women With Inflammatory Bowel Disease: Effects of Therapeutic Strategies on Disease Behavior and Birth Outcomes.

Julsgaard M, Hvas CL, Gearry RB, Gibson PR, Fallingborg J, Sparrow MP, Bibby BM, Connell WR, Brown SJ, Kamm MA, Lawrance IC, Vestergaard T, Svenningsen L, Baekdal M, Kammerlander H, Walsh A, Boysen T, Bampton P, Radford-Smith G, Kjeldsen J, Andrews JM, Subramaniam K, Moore GT, Jensen NM, Connor SJ, Wildt S, Wilson B, Ellard K, Christensen LA, Bell SJ. Julsgaard M, et al. Inflamm Bowel Dis. 2020 Jan 1;26(1):93-102. doi: 10.1093/ibd/izz110. Inflamm Bowel Dis. 2020. PMID: 31141607

2

Anti-TNF-α Use During the Third Trimester of Pregnancy in Women with Moderate-severe Inflammatory Bowel Disease and the Risk of Preterm Birth and Low Birth Weight.

Kammerlander H, Nielsen J, Knudsen T, Kjeldsen J, Friedman S, Nørgård BM. Kammerlander H, et al. Inflamm Bowel Dis. 2017 Nov;23(11):1916-1923. doi: 10.1097/MIB.0000000000001234. Inflamm Bowel Dis. 2017. PMID: 28858070

3

Tailored anti-TNF therapy during pregnancy in patients with IBD: maternal and fetal safety.

de Lima A, Zelinkova Z, van der Ent C, Steegers EA, van der Woude CJ. de Lima A, et al. Gut. 2016 Aug;65(8):1261-8. doi: 10.1136/gutjnl-2015-309321. Epub 2015 May 12. Gut. 2016. PMID: 25966992

4

Concentrations of Adalimumab and Infliximab in Mothers and Newborns, and Effects on Infection.

Julsgaard M, Christensen LA, Gibson PR, Gearry RB, Fallingborg J, Hvas CL, Bibby BM, Uldbjerg N, Connell WR, Rosella O, Grosen A, Brown SJ, Kjeldsen J, Wildt S, Svenningsen L, Sparrow MP, Walsh A, Connor SJ, Radford-Smith G, Lawrance IC, Andrews JM, Ellard K, Bell SJ. Julsgaard M, et al. Gastroenterology. 2016 Jul;151(1):110-9. doi: 10.1053/j.gastro.2016.04.002. Epub 2016 Apr 8. Gastroenterology. 2016. PMID: 27063728

5

Pregnancy and newborn outcome of mothers with inflammatory bowel diseases exposed to anti-TNF-α therapy during pregnancy: three-center study.

Bortlik M, Machkova N, Duricova D, Malickova K, Hrdlicka L, Lukas M, Kohout P, Shonova O, Lukas M. Bortlik M, et al. Scand J Gastroenterol. 2013 Aug;48(8):951-8. doi: 10.3109/00365521.2013.812141. Epub 2013 Jul 8. Scand J Gastroenterol. 2013. PMID: 23834232

6

The Effects of Active IBD During Pregnancy in the Era of Novel IBD Therapies.

de Lima-Karagiannis A, Zelinkova-Detkova Z, van der Woude CJ. de Lima-Karagiannis A, et al. Am J Gastroenterol. 2016 Sep;111(9):1305-12. doi: 10.1038/ajg.2016.254. Epub 2016 Jun 28. Am J Gastroenterol. 2016. PMID: 27349339

7

Anti-TNF Levels in Cord Blood at Birth are Associated with Anti-TNF Type.

Kanis SL, de Lima-Karagiannis A, van der Ent C, Rizopoulos D, van der Woude CJ. Kanis SL, et al. J Crohns Colitis. 2018 Jul 30;12(8):939-947. doi: 10.1093/ecco-jcc/jjy058. J Crohns Colitis. 2018. PMID: 29771301

8

Benefits and Risks Associated With Continuation of Anti-Tumor Necrosis Factor After 24 Weeks of Pregnancy in Women With Inflammatory Bowel Disease : A Nationwide Emulation Trial.

Meyer A, Neumann A, Drouin J, Weill A, Carbonnel F, Dray-Spira R. Meyer A, et al. Ann Intern Med. 2022 Oct;175(10):1374-1382. doi: 10.7326/M22-0819. Epub 2022 Sep 27. Ann Intern Med. 2022. PMID: 36162111 Clinical Trial.

9

Effects of discontinuing anti-tumor necrosis factor therapy during pregnancy on the course of inflammatory bowel disease and neonatal exposure.

Zelinkova Z, van der Ent C, Bruin KF, van Baalen O, Vermeulen HG, Smalbraak HJ, Ouwendijk RJ, Hoek AC, van der Werf SD, Kuipers EJ, van der Woude CJ; Dutch Delta IBD Group. Zelinkova Z, et al. Clin Gastroenterol Hepatol. 2013 Mar;11(3):318-21. doi: 10.1016/j.cgh.2012.10.024. Epub 2012 Oct 25. Clin Gastroenterol Hepatol. 2013. PMID: 23103819

10

The Effect of Disease Activity on Birth Outcomes in a Nationwide Cohort of Women with Moderate to Severe Inflammatory Bowel Disease.

Kammerlander H, Nielsen J, Kjeldsen J, Knudsen T, Friedman S, Nørgård B. Kammerlander H, et al. Inflamm Bowel Dis. 2017 Jun;23(6):1011-1018. doi: 10.1097/MIB.0000000000001102. Inflamm Bowel Dis. 2017. PMID: 28346274

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

156 results

Results by year